Serum Sp17 autoantibody was more sensitive for the efficacy of bisphosphonate treatments in SAPHO syndrome than β-CTx and osteocalcin, which further confirmed that the level correlated strongly with the disease activity and inflammatory status of patients with SAPHO syndrome. The gene discussed is BGLAP; the disease is SAPHO syndrome.